People | June 26, 2026
Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Backed by Phase 3 trial showing 24% lower risk of progression
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
In his 17-year career within Roche, Marco has held key global, regional, and affiliate leadership roles
Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
Subscribe To Our Newsletter & Stay Updated
